Press Releases

19.09.2018 | Nanion Technologies and Ncardia Sign Co-Marketing and Support Agreement to enhance Options for Cardiac Researchers

MUNICH, Germany and COLOGNE, Germany, September 19, 2018-- Nanion Technologies GmbH, a leading provider of instrumentation for ion channel drug discovery and screening, and the Ncardia Group, a leading developer, manufacturer, and service provider of human induced pluripotent stem cells (iPSCs) for safety and efficacy testing announced today that they have entered into a joint marketing and sales promotion agreement.

Continue Reading

07.02.2018 | Søren Friis appointed Director of Global Customer Relations at Nanion

MUNICH, GERMANY February 7, 2018-- Nanion Technologies is pleased to announce that Søren Friis has been promoted to Director of Global Customer Relations at Nanion. Søren Friis was most recently Senior Application scientist at Nanion. He holds a very strong track record in developing advanced assays for automated patch clamp systems and for providing excellent support to customers world-wide in pharmaceutical companies and CROs.

Continue Reading

Cookies make it easier for us to provide you with our services. With the usage of our services you permit us to use cookies.
More information Ok